Global Cytomegalovirus Therapeutics Market

1. Summary

The Global Cytomegalovirus Therapeutics Market was valued at $680 mn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.3% CAGR, to an estimated market size of $923 mn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The Cytomegalovirus (CMV) therapeutics market comprises pharmaceutical interventions, primarily antiviral drugs, used for the prophylaxis and treatment of infections caused by the human herpesvirus type 5. The scope includes therapies for immunocompromised patients, such as solid organ and hematopoietic stem cell transplant recipients, HIV/AIDS patients, and infants with congenital CMV, while excluding general vaccines not yet commercially available.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Cytomegalovirus Therapeutics Market in the period 2025-30:

• The market is experiencing a strategic shift from traditional antivirals like ganciclovir toward novel agents such as maribavir (LIVTENCITY) to overcome drug resistance.
• Increasing global volumes of solid organ and hematopoietic stem cell transplantations are the primary drivers for prophylactic therapy demand.
• There is a growing adoption of oral formulations to facilitate outpatient management and improve patient adherence compared to intravenous treatments.
• Rising prevalence of antiviral resistance in long-term HIV patients is fueling the need for second-line therapies like foscarnet.
• Advancements in diagnostic screening and viral load monitoring are enabling more effective preemptive therapy protocols.
• Significant R&D investment is focused on mRNA-based vaccines and allogeneic T-cell therapies which could disrupt the current treatment paradigm.
• Increased awareness of congenital CMV is driving earlier diagnosis and therapeutic intervention in neonatal care.

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments: